These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3669277)

  • 21. Clinical course of idiopathic dilated cardiomyopathy in children.
    Friedman RA; Moak JP; Garson A
    J Am Coll Cardiol; 1991 Jul; 18(1):152-6. PubMed ID: 2050918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].
    Alieva IN; Blagova OV; Gagarina NV; Nedostup AV; Kogan EA; Sedov VP; Kadochnikova VV; Donnikov AE; Zaidenov VA; Kupriyanova AG; Ternovoy SK
    Ter Arkh; 2017; 89(12):15-27. PubMed ID: 29411756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the one-year mortality of dilated cardiomyopathy.
    Unverferth DV; Magorien RD; Moeschberger ML; Baker PB; Fetters JK; Leier CV
    Am J Cardiol; 1984 Jul; 54(1):147-52. PubMed ID: 6741806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
    Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.
    Aleksova A; Sabbadini G; Merlo M; Pinamonti B; Barbati G; Zecchin M; Bussani R; Silvestri F; Iorio AM; Stolfo D; Dal Ferro M; Dragos AM; Meringolo G; Pyxaras S; Lo Giudice F; Perkan A; di Lenarda A; Sinagra G
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):699-705. PubMed ID: 19474760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sudden death in hypertrophic and dilated cardiomyopathy.
    Koga Y; Ogata M; Kihara K; Tsubaki K; Toshima H
    Jpn Circ J; 1989 Dec; 53(12):1546-56. PubMed ID: 2632825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
    Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy.
    Stelken AM; Younis LT; Jennison SH; Miller DD; Miller LW; Shaw LJ; Kargl D; Chaitman BR
    J Am Coll Cardiol; 1996 Feb; 27(2):345-52. PubMed ID: 8557904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.
    Szabó BM; van Veldhuisen DJ; van der Veer N; Brouwer J; De Graeff PA; Crijns HJ
    Am J Cardiol; 1997 Apr; 79(7):978-80. PubMed ID: 9104918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prognostic indicators of a favorable clinical evolution in dilated cardiomyopathy].
    La Vecchia L; Bedogni F; Ometto R; Mosele GM; Bevilacqua P; Bozzola L; Contin F; Vincenzi M
    Cardiologia; 1994 Feb; 39(2):87-93. PubMed ID: 8013020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy.
    Koga Y; Wada T; Toshima H; Akazawa K; Nose Y
    Heart Vessels; 1993; 8(1):37-41. PubMed ID: 8454562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of serial cardiac assessment and familial screening in patients with dilated cardiomyopathy.
    Grünig E; Benz A; Mereles D; Unnebrink K; Kücherer H; Haass M; Kübler W; Katus HA
    Eur J Heart Fail; 2003 Jan; 5(1):55-62. PubMed ID: 12559216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
    Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
    J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ventricular conduction block patterns on mortality in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
    Li X; Luo R; Fang W; Xu X; Niu G; Xu Y; Fu M; Hua W; Wu X
    BMC Cardiovasc Disord; 2016 Jun; 16():136. PubMed ID: 27296108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
    Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.